Showing 12,461 - 12,480 results of 31,515 for search '(( 50 ((teer decrease) OR (a decrease)) ) OR ( 5 ((fold decrease) OR (nn decrease)) ))', query time: 0.90s Refine Results
  1. 12461

    Post mortem evaluation of inflammation, oxidative stress, and PPARγ activation in a nonhuman primate model of cardiac sympathetic neurodegeneration by Jeanette M. Metzger (8259900)

    Published 2020
    “…<div><p>Cardiac dysautonomia is a common nonmotor symptom of Parkinson’s disease (PD) associated with loss of sympathetic innervation to the heart and decreased plasma catecholamines. …”
  2. 12462
  3. 12463
  4. 12464

    Unsuspected osteochondroma-like outgrowths in the cranial base of Hereditary Multiple Exostoses patients and modeling and treatment with a BMP antagonist in mice by Sayantani Sinha (716150)

    Published 2017
    “…Surprisingly, it is not known whether such tumors also form in endochondral elements of the craniofacial skeleton. Here, we carried out a retrospective analysis of cervical spine MRI and CT scans from 50 consecutive HME patients that included cranial skeletal images. …”
  5. 12465

    Table1_Risk of drug-induced angioedema: a pharmacovigilance study of FDA adverse event reporting system database.xlsx by Maoxia Fan (16914033)

    Published 2024
    “…Based on the individual drug reporting odds ratio (95% confidence interval) as a measure of risk signal strength, the top five drugs are as follows: lisinopril [ROR (95% CI): 46.43 (42.59–50.62)], enalapril [ROR (95% CI): 43.51 (39.88–47.46)], perindopril [ROR (95% CI): 31.17 (27.5–35.32)], alteplase [ROR (95% CI): 29.3 (26.95–31.85)], ramipril [ROR (95% CI): 20.93 (19.66–22.28)]. …”
  6. 12466

    Image_1_Negative Association of Interleukin-33 Plasma Levels and Schistosomiasis Infection in a Site of Polyparasitism in Rural Cameroon.TIF by Severin Donald Kamdem (8069741)

    Published 2019
    “…</p><p>Principal findings: We found a prevalence of 13.5% (37/275), 18.2% (50/275), and 8% (22/275), respectively for schistosomiasis, malaria and hepatitis (B or C) single infections. …”
  7. 12467

    FIGURE 5 from Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer by Siddharth Mehra (15666660)

    Published 2023
    “…<p>Addition of αPD-1 blockade to Uro A treatment further decreases PDAC tumor burden and improves overall survival in PKT mice. …”
  8. 12468

    Image_1_Crop coefficient determination and evapotranspiration estimation of watermelon under water deficit in a cold and arid environment.jpeg by Hengjia Zhang (16381497)

    Published 2023
    “…<p>To investigate the evapotranspiration and crop coefficient of oasis watermelon under water deficit (WD), mild (60%–70% field capacity, FC)and moderate (50%–60% FC) WD levels were set up at the various growth stages of watermelon, including seedling stage (SS), vine stage (VS), flowering and fruiting stage (FS), expansion stage (ES), and maturity stage (MS), with adequate water supply (70%–80% FC) during the growing season as a control. …”
  9. 12469

    A Meta-Analysis of Anti-Vascular Endothelial Growth Factor Remedy for Macular Edema Secondary to Central Retinal Vein Occlusion by Peirong Huang (501361)

    Published 2013
    “…Secondary outcomes showed that a 90% and 77% decreased risk at 6 and 12 months for a loss of 15 letters or more. …”
  10. 12470

    Table 1_Bioelectrical impedance vector analysis in older adults: reference standards from a cross-sectional study.docx by Francesco Campa (20997323)

    Published 2025
    “…Bioimpedance analysis was conducted using a phase-sensitive foot-to-hand technology at 50 kHz. …”
  11. 12471

    DataSheet_1_A CRISPR/Cas9-mediated screen identifies determinants of early plasma cell differentiation.docx by Ermeng Xiong (11176635)

    Published 2023
    “…Defective plasmablast formation caused by Ern1 deletion could not be rescued by the active, spliced form of XBP1 whose processing is dependent on and downstream of IRE1a, suggesting that in early plasma cell differentiation IRE1a acts independently of XBP1. …”
  12. 12472

    Table 2_Bioelectrical impedance vector analysis in older adults: reference standards from a cross-sectional study.docx by Francesco Campa (20997323)

    Published 2025
    “…Bioimpedance analysis was conducted using a phase-sensitive foot-to-hand technology at 50 kHz. …”
  13. 12473

    Table2_Risk of drug-induced angioedema: a pharmacovigilance study of FDA adverse event reporting system database.xlsx by Maoxia Fan (16914033)

    Published 2024
    “…Based on the individual drug reporting odds ratio (95% confidence interval) as a measure of risk signal strength, the top five drugs are as follows: lisinopril [ROR (95% CI): 46.43 (42.59–50.62)], enalapril [ROR (95% CI): 43.51 (39.88–47.46)], perindopril [ROR (95% CI): 31.17 (27.5–35.32)], alteplase [ROR (95% CI): 29.3 (26.95–31.85)], ramipril [ROR (95% CI): 20.93 (19.66–22.28)]. …”
  14. 12474

    Image_3_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

    Published 2024
    “…Among 21 regions, the ASIR trend had the largest increase in Central Latin America (EAPC = 0.42, 95%CI = 0.33–0.50). Conversely, the ASDR and ASR-DALYs experienced the largest decrease in Central Europe (EAPC = −5.10, 95%CI = −5.28 to 4.93) and East Asia (EAPC = −4.07, 95%CI = −4.41 to 3.73), respectively. …”
  15. 12475

    Image_4_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

    Published 2024
    “…Among 21 regions, the ASIR trend had the largest increase in Central Latin America (EAPC = 0.42, 95%CI = 0.33–0.50). Conversely, the ASDR and ASR-DALYs experienced the largest decrease in Central Europe (EAPC = −5.10, 95%CI = −5.28 to 4.93) and East Asia (EAPC = −4.07, 95%CI = −4.41 to 3.73), respectively. …”
  16. 12476

    Image_5_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

    Published 2024
    “…Among 21 regions, the ASIR trend had the largest increase in Central Latin America (EAPC = 0.42, 95%CI = 0.33–0.50). Conversely, the ASDR and ASR-DALYs experienced the largest decrease in Central Europe (EAPC = −5.10, 95%CI = −5.28 to 4.93) and East Asia (EAPC = −4.07, 95%CI = −4.41 to 3.73), respectively. …”
  17. 12477

    Image_1_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

    Published 2024
    “…Among 21 regions, the ASIR trend had the largest increase in Central Latin America (EAPC = 0.42, 95%CI = 0.33–0.50). Conversely, the ASDR and ASR-DALYs experienced the largest decrease in Central Europe (EAPC = −5.10, 95%CI = −5.28 to 4.93) and East Asia (EAPC = −4.07, 95%CI = −4.41 to 3.73), respectively. …”
  18. 12478

    Image_7_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

    Published 2024
    “…Among 21 regions, the ASIR trend had the largest increase in Central Latin America (EAPC = 0.42, 95%CI = 0.33–0.50). Conversely, the ASDR and ASR-DALYs experienced the largest decrease in Central Europe (EAPC = −5.10, 95%CI = −5.28 to 4.93) and East Asia (EAPC = −4.07, 95%CI = −4.41 to 3.73), respectively. …”
  19. 12479

    Image_2_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

    Published 2024
    “…Among 21 regions, the ASIR trend had the largest increase in Central Latin America (EAPC = 0.42, 95%CI = 0.33–0.50). Conversely, the ASDR and ASR-DALYs experienced the largest decrease in Central Europe (EAPC = −5.10, 95%CI = −5.28 to 4.93) and East Asia (EAPC = −4.07, 95%CI = −4.41 to 3.73), respectively. …”
  20. 12480

    Image_6_Measurement of the burdens of neonatal disorders in 204 countries, 1990–2019: a global burden of disease-based study.jpg by Juan Xin (5745998)

    Published 2024
    “…Among 21 regions, the ASIR trend had the largest increase in Central Latin America (EAPC = 0.42, 95%CI = 0.33–0.50). Conversely, the ASDR and ASR-DALYs experienced the largest decrease in Central Europe (EAPC = −5.10, 95%CI = −5.28 to 4.93) and East Asia (EAPC = −4.07, 95%CI = −4.41 to 3.73), respectively. …”